|
시장보고서
상품코드
1697961
세계의 정신과 디지털 바이오마커 시장 규모, 점유율, 동향, 업계 분석 : 유형별, 진료 행위별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type, Clinical Practice, End Use, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 정신과 디지털 바이오마커 시장 규모는 2034년까지 55억 4,377만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
정신과 디지털 바이오마커는 정신건강 상태를 평가하기 위해 디지털 기기를 통해 수집되는 객관적이고 정량화할 수 있는 생리적, 행동학적 데이터 포인트입니다. 정신과 디지털 바이오마커 시장은 인공지능, 웨어러블 헬스 기술, 모바일 기반 정신건강 모니터링의 발전에 힘입어 큰 폭의 성장을 경험하고 있습니다. 우울증, 정신분열증, 불안장애와 같은 정신질환의 유병률 증가는 정신과 디지털 바이오마커 시장 수요를 촉진하고 있으며, 임상의와 연구자들은 정확한 진단과 치료의 개별화를 위해 데이터베이스의 실시간 모니터링 툴을 요구하고 있습니다. 또한 스마트워치, 모바일 앱, AI를 활용한 분석에 바이오센서를 통합하여 환자의 원격 모니터링과 임상적 의사결정을 강화하는 추세도 시장 성장을 가속하고 있습니다.
정신과 디지털 바이오마커 산업 동향은 머신러닝 알고리즘을 활용하여 행동 패턴, 음성 바이오마커, 생리적 신호를 분석하여 예측 정확도와 조기 개입 능력을 향상시키는 방향으로 변화하고 있습니다. 또한 제약사 및 생명공학 기업은 디지털 바이오마커를 임상시험에 접목하여 환자 모집 및 치료 효과 평가를 최적화함으로써 정신과 디지털 바이오마커 시장의 확대를 촉진하고 있습니다. 또한 이해관계자들이 데이터 프라이버시 및 보안 프레임워크를 준수하는 것을 중요시하는 규제 발전과 디지털 헬스 기술에 대한 투자 증가도 시장 역학을 촉진하고 있습니다.
정신과 디지털 바이오마커 시장의 비즈니스 기회는 디지털 바이오마커를 사용하여 개별 환자 데이터를 기반으로 치료 전략을 조정하는 정밀 정신의학 개발에 있습니다. 원격의료 및 가상 정신건강 서비스의 도입이 증가함에 따라 의료 서비스 프로바이더가 디지털 모니터링 솔루션을 원격 치료 모델에 통합하는 것도 시장 기회 중 하나입니다. 디지털 바이오마커가 규제 환경에서 받아들여지고 상환 프레임워크가 진화함에 따라 멀티모달 데이터 통합과 AI 기반 정신건강 분석의 지속적인 기술 혁신이 정신과 의료의 미래 전망을 형성하고 시장은 강력한 성장을 이룰 것으로 예상됩니다.
정신과 디지털 바이오마커 시장 : 분석 개요
유형별로는 스마트워치, 피트니스 트래커, 지속적인 정신건강 모니터링을 위한 웨어러블 EEG 기기에 첨단 바이오센서가 통합되면서 웨어러블 부문이 2024년 정신과용 디지털 바이오마커 시장 점유율을 차지할 것으로 예상됩니다.를 차지할 것으로 예상됩니다.
최종 용도별로는 조기 진단을 위한 정신과 디지털 바이오마커의 채택 증가로 인해 의료 기업 부문이 2024년 가장 큰 시장 점유율을 차지했습니다.
2024년 북미가 정신과 디지털 바이오마커 시장에서 가장 큰 매출 점유율을 차지했는데, 이는 이 지역의 의료 인프라가 첨단화되어 있기 때문입니다.
유럽 시장은 정부의 정신건강 연구 지원 정책으로 인해 예측 기간 중 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
세계 주요 기업의 일례로 Biogen, Brainomix, Clario, Empatica, Huma, IXICO plc, Koneksa Health, PureTech Health PLC, Sonde Health, VivoSense 등을 들 수 있습니다.
목차
제1장 서론
제2장 개요
제3장 분석 방법
제4장 세계의 정신과 디지털 바이오마커 시장 인사이트
- 시장 스냅숏
- 정신과 디지털 바이오마커 시장 역학
- 촉진요인과 기회
- 정신 질환의 유병률 상승
- 웨어러블·모바일 헬스 기술의 진보
- 억제요인과 과제
- 데이터 프라이버시에 관한 우려
- 촉진요인과 기회
- PESTLE 분석
- 정신과 디지털 바이오마커 시장 동향
- 밸류체인 분석
제5장 세계의 정신과 디지털 바이오마커 시장 : 유형별
- 주요 분석 결과
- 서론
- 웨어러블
- 모바일 기반 애플리케이션
- 센서
- 기타
제6장 세계의 정신과 디지털 바이오마커 시장 : 진료 행위별
- 주요 분석 결과
- 서론
- 진단용 정신과 디지털 바이오마커
- 모니터링용 정신과 디지털 바이오마커
- 예측·예후용 정신과 디지털 바이오마커
- 기타
제7장 세계의 정신과 디지털 바이오마커 시장 : 최종 용도별
- 주요 분석 결과
- 서론
- 의료 기업
- 의료 제공자
- 지불자
- 기타
제8장 세계의 정신과 디지털 바이오마커 시장 : 지역별
- 주요 분석 결과
- 서론
- 정신과 디지털 바이오마커 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 유형별(2020-2034년)
- 북미 : 진료 행위별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 진료 행위별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 진료 행위별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 진료 행위별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 진료 행위별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Biogen
- Brainomix
- Clario
- Empatica Inc.
- Huma
- IXICO plc
- Koneksa Health
- PureTech Health PLC
- Sonde Health, Inc.
- VivoSense
- Xiamen AJK Technology Co., Ltd.
The global psychiatric digital biomarkers market size is expected to reach USD 5,543.77 million by 2034, according to a new study by Polaris Market Research. The report "Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type (Wearable, Mobile-Based Applications, Sensors, and Others), Clinical Practice, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Psychiatric digital biomarkers are objective, quantifiable physiological and behavioral data points collected through digital devices to assess mental health conditions. The psychiatric digital biomarkers market is experiencing significant expansion, driven by advancements in artificial intelligence, wearable health technologies, and mobile-based mental health monitoring. The growing prevalence of psychiatric disorders, including depression, schizophrenia, and anxiety, is fueling psychiatric digital biomarkers market demand, as clinicians and researchers seek data-driven, real-time monitoring tools for accurate diagnosis and treatment personalization. The market growth is further supported by the increasing integration of biosensors in smartwatches, mobile apps, and AI-powered analytics, which enhance remote patient monitoring and clinical decision-making.
The psychiatric digital biomarkers industry trends indicate a shift toward leveraging machine learning algorithms to analyze behavioral patterns, voice biomarkers, and physiological signals, improving predictive accuracy and early intervention capabilities. Additionally, pharmaceutical and biotech companies are incorporating digital biomarkers into clinical trials, optimizing patient recruitment and therapeutic efficacy assessments, thereby driving psychiatric digital biomarkers market expansion. Regulatory advancements and increasing investments in digital health technologies are also encouraging market dynamics as stakeholders focus on ensuring compliance with data privacy and security frameworks.
The psychiatric digital biomarkers market opportunities lie in the development of precision psychiatry, where digital biomarkers are used to tailor treatment strategies based on individual patient data. The increasing adoption of telemedicine and virtual mental health services presents another market opportunity; as healthcare providers integrate digital monitoring solutions into remote care models. As digital biomarkers gain regulatory acceptance and reimbursement frameworks evolve, the market is expected to witness robust growth, with continuous innovation in multimodal data integration and AI-driven mental health analytics shaping the future landscape of psychiatric care.
Psychiatric Digital Biomarkers Market Report Highlights
In terms of type, the wearable segment dominated the psychiatric digital biomarkers market share in 2024, due to the growing integration of advanced biosensors in smartwatches, fitness trackers, and wearable EEG devices for continuous mental health monitoring.
Based on end use, the healthcare companies segment accounted for the largest market share in 2024 due to the increasing adoption of psychiatric digital biomarkers for early diagnosis.
In 2024, North America accounted for the largest share of the psychiatric digital biomarkers market revenue due to the region's advanced healthcare infrastructure.
The Europe market is expected to register the highest CAGR during the forecast period due to government initiatives supporting mental health research.
A few of the global key market players are Biogen; Brainomix; Clario; Empatica Inc.; Huma; IXICO plc; Koneksa Health; PureTech Health PLC; Sonde Health, Inc.; and VivoSense.
Polaris Market Research has segmented the psychiatric digital biomarkers market report on the basis of type, clinical practice, end use, and region:
By Type Outlook (Revenue - USD Million, 2020-2034)
- Wearable
- Mobile-Based Applications
- Sensors
- Others
By Clinical Practice Outlook (Revenue - USD Million, 2020-2034)
- Diagnostic Psychiatric Digital Biomarkers
- Monitoring Psychiatric Digital Biomarkers
- Predictive and Prognostic Psychiatric Digital Biomarkers
- Others
By End Use Outlook (Revenue - USD Million, 2020-2034)
- Healthcare Companies
- Healthcare Providers
- Payers
- Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Psychiatric Digital Biomarkers Market Insights
- 4.1. Psychiatric Digital Biomarkers Market - Market Snapshot
- 4.2. Psychiatric Digital Biomarkers Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Mental Health Disorders
- 4.2.1.2. Wearable and Mobile Health Technology Advancements
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Data Privacy Concerns
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Psychiatric Digital Biomarkers Market Trends
- 4.6. Value Chain Analysis
5. Global Psychiatric Digital Biomarkers Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 5.3. Wearable
- 5.3.1. Global Psychiatric Digital Biomarkers Market, by Wearable, by Region, 2020-2034 (USD Million)
- 5.4. Mobile based Applications
- 5.4.1. Global Psychiatric Digital Biomarkers Market, Mobile based Applications, by Region, 2020-2034 (USD Million)
- 5.5. Sensors
- 5.5.1. Global Psychiatric Digital Biomarkers Market, by Sensors, by Region, 2020-2034 (USD Million)
- 5.6. Others
- 5.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)
6. Global Psychiatric Digital Biomarkers Market, by Clinical Practice
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 6.3. Diagnostic Psychiatric Digital Biomarkers
- 6.3.1. Global Psychiatric Digital Biomarkers Market, by Diagnostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
- 6.4. Monitoring Psychiatric Digital Biomarkers
- 6.4.1. Global Psychiatric Digital Biomarkers Market, by Monitoring Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
- 6.5. Predictive and Prognostic Psychiatric Digital Biomarkers
- 6.5.1. Global Psychiatric Digital Biomarkers Market, by Predictive and Prognostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
- 6.6. Others
- 6.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)
7. Global Psychiatric Digital Biomarkers Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 7.3. Healthcare companies
- 7.3.1. Global Psychiatric Digital Biomarkers Market, by Healthcare companies, by Region, 2020-2034 (USD Million)
- 7.4. Healthcare Providers
- 7.4.1. Global Psychiatric Digital Biomarkers Market, by Healthcare Providers, by Region, 2020-2034 (USD Million)
- 7.5. Payers
- 7.5.1. Global Psychiatric Digital Biomarkers Market, by Payers, by Region, 2020-2034 (USD Million)
- 7.6. Others
- 7.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)
8. Global Psychiatric Digital Biomarkers Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Psychiatric Digital Biomarkers Market Assessment, By Geography, 2020-2034 (USD Million)
- 8.3. Psychiatric Digital Biomarkers Market - North America
- 8.3.1. North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.3.2. North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.3.3. North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.3.4. Psychiatric Digital Biomarkers Market - US
- 8.3.4.1. US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.3.4.2. US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.3.4.3. US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.3.5. Psychiatric Digital Biomarkers Market - Canada
- 8.3.5.1. Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.3.5.2. Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.3.5.3. Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4. Psychiatric Digital Biomarkers Market - Europe
- 8.4.1. Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.3. Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.4. Psychiatric Digital Biomarkers Market - UK
- 8.4.4.1. UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.4.2. UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.4.3. UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.5. Psychiatric Digital Biomarkers Market - France
- 8.4.5.1. France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.5.2. France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.5.3. France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.6. Psychiatric Digital Biomarkers Market - Germany
- 8.4.6.1. Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.6.2. Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.6.3. Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.7. Psychiatric Digital Biomarkers Market - Italy
- 8.4.7.1. Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.7.2. Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.7.3. Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.8. Psychiatric Digital Biomarkers Market - Spain
- 8.4.8.1. Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.8.2. Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.8.3. Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.9. Psychiatric Digital Biomarkers Market - Netherlands
- 8.4.9.1. Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.9.2. Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.9.3. Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.10. Psychiatric Digital Biomarkers Market - Russia
- 8.4.10.1. Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.10.2. Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.10.3. Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.11. Psychiatric Digital Biomarkers Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.11.2. Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.11.3. Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5. Psychiatric Digital Biomarkers Market - Asia Pacific
- 8.5.1. Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.4. Psychiatric Digital Biomarkers Market - China
- 8.5.4.1. China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.4.2. China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.4.3. China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.5. Psychiatric Digital Biomarkers Market - India
- 8.5.5.1. India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.5.2. India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.5.3. India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.6. Psychiatric Digital Biomarkers Market - Malaysia
- 8.5.6.1. Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.6.2. Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.6.3. Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.7. Psychiatric Digital Biomarkers Market - Japan
- 8.5.7.1. Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.7.2. Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.7.3. Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.8. Psychiatric Digital Biomarkers Market - Indonesia
- 8.5.8.1. Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.8.2. Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.8.3. Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.9. Psychiatric Digital Biomarkers Market - South Korea
- 8.5.9.1. South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.9.2. South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.9.3. South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.10. Psychiatric Digital Biomarkers Market - Australia
- 8.5.10.1. Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.10.2. Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.10.3. Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.11. Psychiatric Digital Biomarkers Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6. Psychiatric Digital Biomarkers Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.4. Psychiatric Digital Biomarkers Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.5. Psychiatric Digital Biomarkers Market - UAE
- 8.6.5.1. UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.5.2. UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.5.3. UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.6. Psychiatric Digital Biomarkers Market - Israel
- 8.6.6.1. Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.6.2. Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.6.3. Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.7. Psychiatric Digital Biomarkers Market - South Africa
- 8.6.7.1. South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.7.2. South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.7.3. South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.8. Psychiatric Digital Biomarkers Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7. Psychiatric Digital Biomarkers Market - Latin America
- 8.7.1. Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.7.3. Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.4. Psychiatric Digital Biomarkers Market - Mexico
- 8.7.4.1. Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.7.4.2. Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.7.4.3. Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.5. Psychiatric Digital Biomarkers Market - Brazil
- 8.7.5.1. Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.7.5.2. Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.7.5.3. Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.6. Psychiatric Digital Biomarkers Market - Argentina
- 8.7.6.1. Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.7.6.2. Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.7.6.3. Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.7. Psychiatric Digital Biomarkers Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Biogen
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Brainomix
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Clario
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Empatica Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Huma
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. IXICO plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Koneksa Health
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. PureTech Health PLC
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Sonde Health, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. VivoSense
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Xiamen AJK Technology Co., Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
